MANK
COM:MANKINDPHARMA
Mankind Pharma
- Stock
Last Close
2,574.40
21/11 10:00
Market Cap
848.24B
Beta: -
Volume Today
275.52K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | Sep '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 17.26B - | 21.80B 26.32% | 24.26B 11.28% | 20.91B 13.81% | 20.53B 1.83% | 25.79B 25.62% | 27.08B 5.02% | 26.07B 3.73% | 24.41B 6.36% | 28.93B 18.53% | 30.77B 6.33% | |
cost of revenue | 5.73B - | 7.55B 31.91% | 8.06B 6.75% | 7.13B 11.58% | 12.54B 75.91% | 8.20B 34.62% | 8.25B 0.60% | 8.28B 0.33% | 7.37B 10.91% | 15.54B 110.78% | 16.27B 4.69% | |
gross profit | 11.53B - | 14.25B 23.55% | 16.20B 13.68% | 13.78B 14.91% | 7.99B 42.05% | 17.59B 120.22% | 18.83B 7.08% | 17.79B 5.52% | 17.04B 4.25% | 13.39B 21.39% | 14.50B 8.23% | |
selling and marketing expenses | 1.22B - | |||||||||||
general and administrative expenses | 775.55M - | |||||||||||
selling general and administrative expenses | 1.99B - | 4.97B - | 4.66B - | 5.51B 18.12% | 5.31B - | 7.65B 44.08% | 7.05B 7.87% | |||||
research and development expenses | ||||||||||||
other expenses | 17.48M - | 165.38M 846.09% | -305.85M - | 586.19M - | 599.78M 2.32% | 701.33M 16.93% | 921.28M 31.36% | |||||
cost and expenses | 14.87B - | 18.02B 21.20% | 18.83B 4.48% | 16.99B 9.74% | 17.21B 1.26% | 20.11B 16.89% | 21.22B 5.51% | 21.10B 0.55% | 19.55B 7.37% | 23.19B 18.66% | 23.32B 0.55% | |
operating expenses | 9.14B - | 10.47B 14.49% | 10.76B 2.84% | 9.86B 8.37% | 4.66B 52.70% | 11.91B 155.39% | 12.97B 8.89% | 12.83B 1.12% | 12.17B 5.08% | 7.65B 37.13% | 7.05B 7.87% | |
interest expense | 106.34M - | 162.41M 52.72% | 113.32M - | 51.55M 54.51% | 63.40M 22.97% | 86.24M 36.03% | 91.85M 6.51% | 93.82M 2.14% | 109.10M 16.28% | 71M 34.92% | ||
ebitda | 2.96B - | 4.76B 60.75% | 5.52B 15.87% | 4.75B 13.90% | 4.17B 12.30% | 7.18B 72.35% | 7.46B 3.89% | 6.81B 8.69% | 6.86B 0.65% | 6.82B 0.57% | 9.59B 40.73% | |
operating income | 2.49B - | 3.98B 59.99% | 5.12B 28.61% | 3.90B 23.78% | 3.32B 14.90% | 6.31B 89.91% | 6.50B 2.98% | 5.72B 12.02% | 5.81B 1.65% | 5.74B 1.19% | 7.44B 29.69% | |
depreciation and amortization | 473.58M - | 780.16M 64.74% | 396.89M 49.13% | 847.91M 113.64% | 845.21M 0.32% | 873.55M 3.35% | 964.85M 10.45% | 1.10B 13.72% | 1.05B 4.59% | 1.08B 2.92% | 1.06B 1.97% | |
total other income expenses net | 141.57M - | -162.41M 214.72% | 208.87M 228.61% | -113.32M 154.25% | 423.56M 473.77% | -63.40M 114.97% | -86.24M 36.03% | -91.85M 6.51% | -93.82M 2.14% | 896.90M 1,055.96% | 1.02B 14.09% | |
income before tax | 2.63B - | 3.82B 45.21% | 5.33B 39.55% | 3.79B 28.90% | 3.75B 1.18% | 6.24B 66.74% | 6.41B 2.65% | 5.62B 12.27% | 5.72B 1.64% | 6.64B 16.12% | 8.47B 27.58% | |
income tax expense | 703.33M - | 843.20M 19.89% | 1.10B 30.91% | 832.70M 24.57% | 835.87M 0.38% | 1.30B 55.86% | 1.30B 0.36% | 1.03B 21.03% | 949.84M 7.35% | 1.25B 31.13% | 1.90B 52.90% | |
net income | 1.90B - | 2.93B 53.91% | 4.20B 43.46% | 2.84B 32.30% | 2.85B 0.45% | 4.87B 70.57% | 5.01B 2.91% | 4.54B 9.43% | 4.71B 3.85% | 5.36B 13.85% | 6.53B 21.80% | |
weighted average shs out | 400.59M - | 400.59M 0% | 400.49M 0.03% | 400.59M - | 400.59M 0.00% | 400.50M 0.02% | 400.49M 0.00% | 400.64M - | 400.64M 0.00% | |||
weighted average shs out dil | 400.59M - | 400.59M 0% | 400.49M 0.03% | 400.59M - | 400.59M 0% | 401.14M 0.14% | 401.20M 0.02% | 401.26M - | 401.39M 0.03% | |||
eps | 4.74 - | 7.30 54.01% | 10.48 43.56% | 0 100% | 7.13 Infinity% | 12.15 70.41% | 12.51 2.96% | 11.33 9.43% | 11.76 3.80% | 13.39 13.86% | 16.31 21.81% | |
epsdiluted | 4.74 - | 7.30 54.01% | 10.48 43.56% | 0 100% | 7.13 Infinity% | 12.15 70.41% | 12.49 2.80% | 11.31 9.45% | 11.74 3.80% | 13.37 13.88% | 16.28 21.77% |
All numbers in (except ratios and percentages)